Primary Care POC Diagnostics Market Poised to Hit $22.88 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Primary Care POC Diagnostics Market Size Growth Forecast: What to Expect by 2025?
The sphere of point-of-care diagnostics within primary care settings has experienced robust expansion lately, projected to increase its valuation from $16.35 billion in 2024 to $17.38 billion the following year, representing a compound annual growth rate of 6.3%. This historical upward trajectory is largely explainable by the mounting incidence of long-term health conditions, the transition to tailored medical treatments, the escalation of overall healare spending, the development of favorable regulatory environments alongside accelerated authorization pathways, and a heightened focus on identifying illnesses at their onset and implementing proactive wellness approaches.

How Will the Primary Care POC Diagnostics Market Size Evolve and Grow by 2029?
Anticipated robust expansion characterizes the primary care point-of-care (POC) diagnostics sector, projected to reach a valuation of $22.88 billion by 2029, driven by a compound annual growth rate (CAGR) of 7.1% throughout this projection timeframe, with this upward trajectory fueled by several factors including the reoccurrence of infectious disease events, the broadening utility across chronic, non-communicable ailments, heightened utilization within home-based medical care environments, momentum behind personalized medicine programs, augmented capital expenditure in medical infrastructure, the increasing prevalence of various illnesses, and a heightened understanding regarding the benefits derived from identifying diseases sooner; concurrently, significant shifts defining this period involve the incorporation of artificial intelligence and machine learning methods, progress in technologies underpinning molecular testing, a trend toward smaller and more mobile POC diagnostic instruments, the linkage of these devices with smart technology ecosystems, and the increased deployment of testing methods that simultaneously analyze multiple targets or employ comprehensive panels within POC settings.

View the full report here:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

What Drivers Are Propelling the Growth of Primary Care POC Diagnostics Market Forward?
Anticipated increases in how frequently infectious illnesses appear are projected to boost the expansion of the point-of-care diagnostics sector within primary healare moving forward.Pathogens like bacteria, viruses, fungi, or parasites are the agents responsible for these ailments, which transmit between individuals either directly or indirectly via contact with tainted environments, airborne particles, water sources, or disease carriers such as insects.Factors contributing to the spread of these conditions include substandard environmental quality, the movement towards city living, resistance to antibiotics, and insufficient immunization rates.Point-of-care diagnostics utilized in primary care are essential instruments for addressing the widespread nature of infectious diseases because they enable swift identification, prompt therapeutic intervention, and successful public health management across various medical environments.To illustrate this trend, data released in October 2023 by the UK Health Security Agency, an entity overseeing public health security in the United Kingdom, showed that HIV diagnoses within England climbed by 22 percent, moving from 3,118 cases in 2021 to 3,805 in 2022.Moreover, the World Health Organization (WHO), a UN agency headquartered in Switzerland focused on global health, indicated in November 2023 that approximately 10.6 million tuberculosis (TB) cases were registered worldwide during 2022, affecting 5.8 million males, 3.5 million females, and 1.3 million youngsters.Consequently, this escalating incidence of infectious diseases is acting as a key impetus for growth within the primary care POC diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

Which Emerging Trends Are Transforming the Primary Care POC Diagnostics Market in 2025?
Leading entities within the foremost segment of point-of-care diagnostics are strategically prioritizing the development of sophisticated technological offerings, specifically portable point-of-care RT-PCR systems, as a means to boost their market earnings.These portable point-of-care (POC) RT-PCR systems represent compact, mobile apparatuses engineered for executing real-time reverse transcription polymerase chain reaction (RT-PCR) analyses away from conventional laboratory environments.To illustrate, in October of 2022, Genes2Me Pvt. Ltd., an Indian producer specializing in molecular diagnostic instrumentation, introduced its Rapi-Q Point of Care RT PCR offering, targeting ailments like tuberculosis and HPV.This specific system features an eight-well configuration equipped with four fluorescent detection channels, lauded for its simplicity of operation and capacity to deliver rapid confirmation in under forty-five minutes.Being both lightweight and easily transportable, the Rapi-Q platform proves advantageous for deployment across diverse settings including healare facilities, blood repositories, outpatient clinics, investigative labs, and air travel hubs.The device demonstrates superior capability regarding sensitivity, precision, and efficacy in identifying numerous pathogens, further enhanced by its compatibility with more than fifty different disease detection kits that are shelf-stable at ambient temperatures.

What Are the Key Segments in the Primary Care POC Diagnostics Market?
The primary care poc diagnosticsmarket covered in this report is segmented -

1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products
2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses

Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Who Are the Key Players Shaping the Primary Care POC Diagnostics Market's Competitive Landscape?
Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, inson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

What Geographic Markets Are Powering Growth in the Primary Care POC Diagnostics Market?
North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15642

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQThis Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.